Webinar: On the brink of commercialisation – Watch on demand

A Watson Marlow Fluid Technology Solutions webinar with insights from NIBRT’s Training Director John Milne

Title: On the brink of commercialisation – Addressing the challenges of commercialisation for cell and gene therapies/ATMPs
Duration: 58 minutes
Delivery: On Demand

Many novel cell and gene therapies (CGTs) are now entering the commercialization stage but, as developers look to recoup investment and quickly deliver life-saving therapies to the patients that need them, they face a myriad of challenges. 

In this webinar, learn how advanced therapy medicinal product (ATMP) platforms, using single-use systems, are delivering streamlined, efficient and cost-effective manufacturing solutions in this dynamic sector.

Key discussion points include:

• The key attributes of ATMP platforms that deliver efficient manufacturing.
• The importance of developing process design around single-use systems. 
• Training to meet the skills challenge
• Case studies using modular ATMP platforms.